NCT02119780

Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 83 (estimated)
• Sponsor: LG Life Sciences · Industry
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study is purposed to evaluate the efficacy and safety of YVOIRE® contour compared with Restylane SubQ™ injected into the anteromedial malar region.

Conditions

• Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region

Interventions

Type	Name	Description
DEVICE	YVOIRE® contour	YVOIRE® contour injection into the anteromedial malar region
DEVICE	Restylane SubQ™	Restylane SubQ™ injection into the anteromedial malar region

Timeline

• Start date: 2014-05-01
• Primary completion: 2014-10-01
• First posted: 2014-04-22
• Last updated: 2015-10-05

Locations

1 site across 1 country: South Korea